Is Coronary Artery Ectasia a Progressive Disease? A Self-Controlled Retrospective Cohort Study

Ruifeng Liu1, Huiqiang Zhao1, Xiangyu Gao1

  • 1Department of Cardiology, Beijing Friendship Hospital Affiliated to Capital Medical University, Beijing, China.

Insights

Coronary artery ectasia (CAE) showed minimal progression over 1-16 years in patients with atherosclerosis. Atherosclerosis itself worsened, indicating that managing these atherosclerotic changes is clinically more significant than focusing on ectasia.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Medical Imaging

Background:

  • Coronary artery ectasia (CAE) poses risks like rupture, necessitating understanding of its progression.
  • Stent implantation may be contraindicated if ectatic changes advance.

Purpose of the Study:

  • To evaluate the longitudinal progression of coronary artery ectasia (CAE) in patients with atherosclerosis.
  • To determine if ectatic changes in coronary arteries evolve over time and their relationship with atherosclerosis progression.

Main Methods:

  • Retrospective analysis of 99 CAE patients with at least two coronary angiograms over 1-16 years.
  • Comparison of clinical characteristics and coronary artery imaging parameters between baseline and follow-up.
  • Multilinear regression analysis to identify factors associated with stenosis evolution.

Main Results:

  • CAE showed minimal progression in extent (vessel involvement, type, diameter, length) over the follow-up period.
  • Significant progression of atherosclerosis, indicated by increased stenosis and Gensini scores, was observed.
  • Factors influencing stenosis progression included longer follow-up, lower baseline Gensini score, and higher hs-CRP levels. Ectatic diameter correlated with stenosis extent.

Conclusions:

  • Coronary artery ectasia (CAE) exhibits minimal progression over 1-16 years in patients with atherosclerosis.
  • Atherosclerosis progression is significant in these patients, with ectasia extent linked to stenosis severity.
  • Management of atherosclerotic changes is likely more clinically impactful than interventions targeting ectasia itself.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
470
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
76
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
60
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
63
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
82
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
40